Ana Lucrecia Woodward

Array ( [id] => 6098505 [patent_doc_number] => 20110003995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Process for the Preparation of Ziprasidone' [patent_app_type] => utility [patent_app_number] => 12/921566 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4080 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003995.pdf [firstpage_image] =>[orig_patent_app_number] => 12921566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020482 [patent_doc_number] => 08530468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Bicyclylaryl-aryl-amine compounds and their use' [patent_app_type] => utility [patent_app_number] => 12/918266 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42363 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392240 [patent_doc_number] => 20090209553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Arylpiperazine derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/378366 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15208 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209553.pdf [firstpage_image] =>[orig_patent_app_number] => 12378366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496407 [patent_doc_number] => 20090264435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Novel Aryl- and Heteroarylpiperazines' [patent_app_type] => utility [patent_app_number] => 12/367952 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33813 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264435.pdf [firstpage_image] =>[orig_patent_app_number] => 12367952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173897 [patent_doc_number] => 07659276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Melanin concentrating hormone receptor antagonist' [patent_app_type] => utility [patent_app_number] => 12/367083 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52740 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659276.pdf [firstpage_image] =>[orig_patent_app_number] => 12367083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527794 [patent_doc_number] => 20090197871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Dual Pharmacophores - PDE4-Muscarinic Antagonistics' [patent_app_type] => utility [patent_app_number] => 12/365934 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113080 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197871.pdf [firstpage_image] =>[orig_patent_app_number] => 12365934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480720 [patent_doc_number] => 20090203677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Dual Pharmacophores - PDE4-Muscarinic Antagonistics' [patent_app_type] => utility [patent_app_number] => 12/365933 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79461 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203677.pdf [firstpage_image] =>[orig_patent_app_number] => 12365933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480700 [patent_doc_number] => 20090203657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Dual Pharmacophores - PDE4-Muscarinic Antagonistics' [patent_app_type] => utility [patent_app_number] => 12/365930 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72936 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203657.pdf [firstpage_image] =>[orig_patent_app_number] => 12365930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527818 [patent_doc_number] => 20090197895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'OXAZOLE-PYRROLE-PIPERAZINE ALPHA-HELIX MIMETIC' [patent_app_type] => utility [patent_app_number] => 12/362934 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10330 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197895.pdf [firstpage_image] =>[orig_patent_app_number] => 12362934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6006988 [patent_doc_number] => 20110059019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'NOVEL ARYL PIPERAZINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/865410 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4418 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059019.pdf [firstpage_image] =>[orig_patent_app_number] => 12865410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944902 [patent_doc_number] => 20110105522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'KETOCONAZOLE-DERIVATIVE ANTAGONIST OF HUMAN PREGNANE X RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/735368 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10289 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105522.pdf [firstpage_image] =>[orig_patent_app_number] => 12735368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196732 [patent_doc_number] => 20110028490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => '4-PHENYL-PIPERAZIN-1-YL-ALKYL-BENZOIMIDAZOL-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE IN-HIBITORS' [patent_app_type] => utility [patent_app_number] => 12/812272 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6239 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028490.pdf [firstpage_image] =>[orig_patent_app_number] => 12812272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279303 [patent_doc_number] => 20090131435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/356428 [patent_app_country] => US [patent_app_date] => 2009-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 50296 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131435.pdf [firstpage_image] =>[orig_patent_app_number] => 12356428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388520 [patent_doc_number] => 20100317672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 12/812973 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6387 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317672.pdf [firstpage_image] =>[orig_patent_app_number] => 12812973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591238 [patent_doc_number] => 07662823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 12/354308 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99419 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662823.pdf [firstpage_image] =>[orig_patent_app_number] => 12354308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944903 [patent_doc_number] => 20110105523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'BIFEPRUNOX DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/812788 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4232 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105523.pdf [firstpage_image] =>[orig_patent_app_number] => 12812788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4566135 [patent_doc_number] => 07846934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/319550 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28210 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846934.pdf [firstpage_image] =>[orig_patent_app_number] => 12319550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447868 [patent_doc_number] => 20100280043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PYRAZOLOPYRIDINES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/812448 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40106 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280043.pdf [firstpage_image] =>[orig_patent_app_number] => 12812448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355562 [patent_doc_number] => 20090186906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Furo[3, 2-b] pyrrol derivatives' [patent_app_type] => utility [patent_app_number] => 12/319557 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28635 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186906.pdf [firstpage_image] =>[orig_patent_app_number] => 12319557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480757 [patent_doc_number] => 20090203714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/319556 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26800 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203714.pdf [firstpage_image] =>[orig_patent_app_number] => 12319556 [rel_patent_id] =>[rel_patent_doc_number] =>)